Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep 6;102(36):12771-6.
doi: 10.1073/pnas.0505758102. Epub 2005 Aug 23.

Effects of the tumor inhibitory triterpenoid avicin G on cell integrity, cytokinesis, and protein ubiquitination in fission yeast

Affiliations

Effects of the tumor inhibitory triterpenoid avicin G on cell integrity, cytokinesis, and protein ubiquitination in fission yeast

Jordan U Gutterman et al. Proc Natl Acad Sci U S A. .

Abstract

Avicins comprise a class of triterpenoid compounds that exhibit tumor inhibitory activity. Here we show that avicin G is inhibitory to growth of the fission yeast Schizosaccharomyces pombe. S. pombe cells treated with a lethal concentration of avicin G (20 microM) exhibited a shrunken morphology, indicating that avicin G adversely affects cell integrity. Cells treated with a sublethal concentration of avicin G (6.5 microM) exhibited a strong cytokinesis-defective phenotype (multiseptated cells), as well as cell morphology defects. These phenotypes bear resemblance to those resulting from loss of Rho1 GTPase function in S. pombe. Indeed, Rho1-deficient S. pombe cells were strongly hypersensitive to avicin G, suggesting that the compound may perturb Rho1-dependent processes. Consistent with previously observed effects in human Jurkat T cells, avicin G treatment resulted in hyperaccumulation of ubiquitinated proteins in S. pombe cells. Interestingly, proteasome-defective S. pombe mutants were not markedly hypersensitive to avicin G, whereas an anaphase-promoting complex (mitotic ubiquitin ligase) mutant exhibited avicin G resistance, suggesting that the increase in levels of ubiquitinated proteins resulting from avicin G treatment may be due to increased protein ubiquitination, rather than inhibition of 26S proteasome activity. Mutants defective in the cAMP/PKA pathway also exhibited resistance to avicin G. Our results suggest that S. pombe will be a useful model organism for elucidating molecular targets of avicin G and serve as a guide to clinical application where dysfunctional aspects of Rho and/or ubiquitination function have been demonstrated as in cancer, fibrosis, and inflammation.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Avicin G inhibits S. pombe cell growth. (A) Wild-type S. pombe cells (105) were spread on a YEAU plate. Five-microliter volumes of a 1:4 dilution series of avicin G (dissolved in water) were spotted onto the cell lawn (0.1–25 μg of drug), which were incubated for 3 days at 30°C. Five microliters of water was spotted on the plate as a control (C). Growth inhibition (circular areas devoid of cell growth) was observed where 1.6 μg, 6.3 μg, and 25 μg amounts of the drug were spotted. (B) Wild-type S. pombe cells were incubated in YEAU (control) or YEAU containing the indicated concentrations of avicin G and monitored for growth for 12 h. Cell densities (cells per ml) were determined microscopically by using a hemacytometer. (C) Wild-type S. pombe cells were incubated in YEAU to low density, then diluted with fresh YEAU to a density of 2.5 × 105 cells per ml. Avicin G was added to half the culture to a final concentration of 20 μg/ml, and an equal volume of water was added to the remaining culture. At 1, 2, 4, and 8 h, 10-ml portions of each culture were pelleted by centrifugation, washed twice with YEAU, and resuspended in YEAU. Cell densities were determined by using a hemacytometer, and 2,000 cells from each sample were spread onto YEAU plates. After 3 days, colonies were counted. The graph shows the frequency of cell viability (based on colony-forming units) of untreated and avicin G-treated cultures at the indicated time points. Duplicate samples were cultured for each time point.
Fig. 2.
Fig. 2.
Microscopic analysis of avicin G-treated S. pombe cells. Photomicrographs of wild-type S. pombe cells incubated in YEAU (A) or YEAU containing 40 μg/ml avicin G (B) for 10 h. The majority of avicin G-treated cells were shrunken in appearance. (C) Photomicrograph of wild-type S. pombe cells treated with a sublethal concentration of avicin G (10 μg/ml) for 10 h. A high frequency of cells contained multiple septa. (D) Fluorescence photomicrograph of DAPI-stained S. pombe cells treated with 10 μg/ml avicin G for 10 h. Three multiseptated cells are shown, the compartments of which each contained a single nucleus.
Fig. 3.
Fig. 3.
Rho1-deficient S. pombe cells are hypersensitive to avicin G. (A) Wild-type and nmt41-rho1 cells were overlaid onto EMM (Upper) or EMM plus 0.1 μM thiamine (EMMT) (Lower) as described for Fig. 1. Avicin G (25 μg) was spotted onto each cell lawn, and the plates were incubated for 3 days at 30°C. On EMMT plates, but not EMM plates, the area of avicin G-induced growth inhibition was significantly greater for nmt41-rho1 lawns than the wild-type cell lawns. (B) Relative avicin G sensitivity of wild-type and nmt41-rho1 cells based on areas of growth inhibition from two separate drug sensitivity tests of the type shown in A. Avicin G sensitivity of wild-type cells was normalized to a value of 1. (C) Serial dilutions (1:5) of wild-type and nmt41-rho1 cells were spotted onto EMMT or EMMT containing 8 μg/ml avicin G and incubated for 5 days at 30°C. Wild-type cells grew on the avicin G plate, whereas nmt41-rho1 cells did not.
Fig. 4.
Fig. 4.
Relative avicin G sensitivities of stress-response-defective S. pombe mutants. (A) Wild-type and spc1Δ S. pombe strains were overlaid onto YEAU plates as described in Fig. 1. Avicin G (25 μg) was then spotted onto the respective cell lawns, and the plates were incubated at 30°C for 3 days. The relative avicin G sensitivity of each strain, based on measurements of areas of avicin G-induced growth inhibition, was then determined, with wild-type cells being normalized to a value of 1. (B) Serial dilutions (1:5) of wild-type, cyr1Δ, pka1Δ, and plb1Δ cells were spotted onto YEAU or YEAU containing 16 μg/ml avicin G and incubated for 3 days at 30°C. cyr1Δ, pka1Δ, and plb1Δ cells, but not wild type, grew on the avicin-G-containing plate.
Fig. 5.
Fig. 5.
Avicin G causes hyperaccumulation of ubiquitinated proteins in S. pombe cells. Wild-type S. pombe cells were incubated in YEAU containing 20 μg/ml avicin G for the time indicated (h), then processed for immunoblot analysis of ubiquitinated proteins. An increase in the levels of ubiquitinated proteins was detected after 1.5 h of avicin G treatment.
Fig. 6.
Fig. 6.
Effects of avicin G on the growth of 26S proteasome and APC-defective S. pombe mutants. Wild-type, mts2-1 (mts2), mts3-1 (mts3), and nuc2-663 cells were spread onto a YEAU plates as described for Fig. 1. Avicin G (25 μg) was then spotted onto the respective cell lawns, and the plates were incubated at 26°C for 5 days. The relative avicin G sensitivity of each strain, based on measurements of areas of avicin G-induced growth inhibition, was then determined, with wild-type cells being normalized to a value of 1. (B) Serial dilutions (1:5) of wild-type and nuc2-663 cells were spotted onto YEAU or YEAU containing 16 μg/ml avicin G and incubated for 5 days at 26°C. nuc2-663 cells, but not wild-type cells, grew on the avicin G-containing plate.

References

    1. Haridas, V., Arntzen, C. J. & Gutterman, J. U. (2001) Proc. Natl. Acad. Sci. USA 98, 11557–11562. - PMC - PubMed
    1. Haridas, V., Higuchi, M., Jayatilake, G. S., Bailey, D., Mujoo, K., Blake, M. E., Arntzen, C. J. & Gutterman, J. U. (2001) Proc. Natl. Acad. Sci. USA 98, 5821–5826. - PMC - PubMed
    1. Haridas, V., Hanausek, M., Nishimura, G., Soehnge, H., Gaikwad, A., Narog, M., Spears, E., Zoltaszek, R., Walaszek, Z. & Gutterman, J. U. (2004) J. Clin. Invest. 113, 65–73. - PMC - PubMed
    1. Hanausek, M., Ganesh, P., Walaszek, Z., Arntzen, C. J., Slaga, T. J. & Gutterman, J. U. (2001) Proc. Natl. Acad. Sci. USA 98, 11551–11556. - PMC - PubMed
    1. Mujoo, K., Haridas, V., Hoffmann, J. J., Wachter, G. A., Hutter, L. K., Lu, Y., Blake, M. E., Jayatilake, G. S., Bailey, D., Mills, G. B. & Gutterman, J. U. (2001) Cancer Res. 61, 5486–5490. - PubMed

Publication types

MeSH terms

LinkOut - more resources